Additionally, numerous diseases caused by viral infections have significantly higher levels of IL-6 expression, which is positively correlated with disease severity.[9] Inflammatory cytokine levels have been shown to be considerably higher in severe COVID-19 cases than in mild cases, with IL-6 being a critical mediator of hyperinflammation.[6] The goal of this study was to examine the potential factors that influence serum interleukin-6 levels, as well as their relationship to COVID-19 disease outcomes in an ethnically diverse population living in the United Arab Emirates. This evidence concerns the gene IL6 and COVID-19.